. 2001; 18(2): 127-130 | |||
Myelotoxicity of Cyclophosphamide, Methotrexate and 5-fluorouracil Regimen in the Early Stage Breast Cancer Patients with Diabetes MellitusHasan Üstün, Sabri Barutca, Esin Şanlı, Mine Çabuk, Mehmet AlakavuklarDepartment Of Adult Hematology-oncology, Faculty Of Medicine, Dokuz Eylül University, İzmir, TurkeyCMF (cyclophosphamide, methotrexate and 5-fluorouracil) is one of the most commonly used chemotherapy (CT) regimens in breast cancer. To the best of our knowledge there are no published studies on the toxicity of this regimen in the existence of diabetes mellitus (DM), in the literature. We retrospectively analyzed the myelotoxicity of CMF CT after 40 adjuvant cycles of 18 diabetics, according to WHO toxicity scala. Leucopenia/ Hasan Üstün, Sabri Barutca, Esin Şanlı, Mine Çabuk, Mehmet Alakavuklar. Myelotoxicity of Cyclophosphamide, Methotrexate and 5-fluorouracil Regimen in the Early Stage Breast Cancer Patients with Diabetes Mellitus. . 2001; 18(2): 127-130 Sorumlu Yazar: Sabri Barutca, Türkiye |
|